Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000420568 | SCV000534966 | uncertain significance | not provided | 2016-12-23 | criteria provided, single submitter | clinical testing | The M587L variant in the PHKB gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The M587L variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The M587L variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Methionine are tolerated across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret M587L as a variant of uncertain significance. |
Invitae | RCV001504981 | SCV001709869 | likely benign | Glycogen storage disease IXb | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925295 | SCV004740155 | likely benign | PHKB-related condition | 2023-09-29 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |